Электронный архив

Просмотр по автору "Lothion-Roy J."

Просмотр по автору "Lothion-Roy J."

Отсортировать по:Сортировать:Результаты поиска на странице:

  • Immunohistochemical Characterisation of GLUT1, MMP3 and NRF2 in Osteosarcoma 
    Rutland C.S.; Cockcroft J.M.; Lothion-Roy J.; Harris A.E.; Jeyapalan J.N.; Simpson S.; Alibhai A.; Bailey C.; Ballard-Reisch A.C.; Rizvanov A.A.; Dunning M.D.; de Brot S.; Mongan N.P. (2021)
    Osteosarcoma (OSA) is an aggressive bone malignancy. Unlike many other malignancies, OSA outcomes have not improved in recent decades. One challenge to the development of better diagnostic and therapeutic methods for OSA ...
  • Metadherin: A therapeutic target in multiple cancers 
    Dhiman G.; Srivastava N.; Goyal M.; Rakha E.; Lothion-Roy J.; Mongan N.; Miftakhova R.; Khaiboullina S.; Rizvanov A.; Baranwal M. (2019)
    Copyright © 2019 Dhiman, Srivastava, Goyal, Rakha, Lothion-Roy, Mongan, Miftakhova, Khaiboullina, Rizvanov and Baranwal. Altered expression of many genes and proteins is essential for cancer development and progression. ...
  • Molecular characterisation of canine osteosarcoma in high risk breeds 
    Simpson S.; Dunning M.; de Brot S.; Alibhai A.; Bailey C.; Woodcock C.L.; Mestas M.; Akhtar S.; Jeyapalan J.N.; Lothion-Roy J.; Emes R.D.; Allegrucci C.; Rizvanov A.A.; Mongan N.P.; Rutland C.S. (2020)
    © 2020 by the authors. Licensee MDPI, Basel, Switzerland. Dogs develop osteosarcoma (OSA) and the disease process closely resembles that of human OSA. OSA has a poor prognosis in both species and disease-free intervals and ...

Поиск в электронном архиве

Просмотр

Моя учетная запись